Belimumab Injection
Sponsors
Leiden University Medical Center, Nanjing University School of Medicine
Conditions
Lupus Erythematosus, SystemicLupus NephritisRemissionSafety Issues
Phase 3
Synergetic B-cell Immunomodulation in SLE - 2nd Study.
Active, not recruitingNCT03747159
Start: 2018-10-01End: 2026-06-07Target: 70Updated: 2024-10-17
Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis
NCT05863936
Start: 2023-04-01End: 2024-12-31Target: 15Updated: 2023-05-18